Induction of insulin secretion by apolipoprotein M, a carrier for sphingosine 1-phosphate

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1841, Issue 9, 2014, Pages 1217-1226

  Kurano, Makoto ^a   Hara, Masumi ^c   Tsuneyama, Koichi ^d   Sakoda, Hideyuki ^b   Shimizu, Tomo ^e   Tsukamoto, Kazuhisa ^f   Ikeda, Hitoshi ^a,g   Yatomi, Yutaka ^a,g  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c TEIKYO UNIVERSITY MIZONOKUCHI HOSPITAL   (Japan)

^d UNIVERSITY OF TOYAMA   (Japan)

^e SEKISUI CHEMICAL CO LTD   (Japan)

^f FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^g UNIVERSITY OF TOKYO HOSPITAL   (Japan)

Author keywords

Apolipoprotein M; Insulin secretion; MIN6 cells; Sphingosine 1 phosphate

Indexed keywords

2 AMINO 2 (3 OCTYLPHENYLCARBAMOYL)ETHYL PHOSPHATE; ADENOVIRUS VECTOR; ADENYLATE KINASE; APOLIPOPROTEIN M; GLUCOSE; INSULIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; SPHINGOSINE 1 PHOSPHATE; TRANSCRIPTION FACTOR PDX 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENDOPLASMIC RETICULUM STRESS; ENZYME PHOSPHORYLATION; GENE OVEREXPRESSION; GENE TRANSFER; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; GLUCOSE TOLERANCE TEST; HEPG2 CELL LINE; IN VITRO STUDY; IN VIVO STUDY; INFANT; INSULIN RELEASE; INSULIN SENSITIVITY; INSULIN TOLERANCE TEST; MIN6 CELL LINE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; VIRAL GENE DELIVERY SYSTEM;

APOLIPOPROTEIN M; INSULIN SECRETION; MIN6 CELLS; SPHINGOSINE 1-PHOSPHATE;

ADENOVIRIDAE; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; APOLIPOPROTEINS; BIOLOGICAL TRANSPORT; BLOOD GLUCOSE; CELL LINE; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION; GENETIC VECTORS; HOMEODOMAIN PROTEINS; INSULIN; INSULIN-SECRETING CELLS; LYSOPHOSPHOLIPIDS; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, LYSOSPHINGOLIPID; SIGNAL TRANSDUCTION; SPHINGOSINE; TRANS-ACTIVATORS;

EID: 84903537675     PISSN: 13881981     EISSN: 18792618     Source Type: Journal    
DOI: 10.1016/j.bbalip.2014.05.002     Document Type: Article

References (38)

1. K.J. Chang-Chen, R. Mullur, and E. Bernal-Mizrachi Beta-cell failure as a complication of diabetes Rev. Endocr. Metab. Disord. 9 2008 329 343
2. C. Mineo, and P.W. Shaul Novel biological functions of high-density lipoprotein cholesterol Circ. Res. 111 2012 1079 1090
3. M.A. Fryirs, P.J. Barter, M. Appavoo, B.E. Tuch, F. Tabet, A.K. Heather, and K.A. Rye Effects of high-density lipoproteins on pancreatic beta-cell insulin secretion Arterioscler. Thromb. Vasc. Biol. 30 2010 1642 1648
4. M. Koren-Gluzer, M. Aviram, E. Meilin, and T. Hayek The antioxidant HDL-associated paraoxonase-1 (PON1) attenuates diabetes development and stimulates beta-cell insulin release Atherosclerosis 219 2011 510 518
5. R.P. Dullaart, W. Annema, J.F. de Boer, and U.J. Tietge Pancreatic beta-cell function relates positively to HDL functionality in well-controlled type 2 diabetes mellitus Atherosclerosis 222 2012 567 573
6. S. Rutti, J.A. Ehses, R.A. Sibler, R. Prazak, L. Rohrer, S. Georgopoulos, D.T. Meier, N. Niclauss, T. Berney, M.Y. Donath, and A. von Eckardstein Low- and high-density lipoproteins modulate function, apoptosis, and proliferation of primary human and murine pancreatic beta-cells Endocrinology 150 2009 4521 4530
7. J. Petremand, J. Puyal, J.Y. Chatton, J. Duprez, F. Allagnat, M. Frias, R.W. James, G. Waeber, J.C. Jonas, and C. Widmann HDLs protect pancreatic beta-cells against ER stress by restoring protein folding and trafficking Diabetes 61 2012 1100 1111
8. W.S. Davidson, R.A. Silva, S. Chantepie, W.R. Lagor, M.J. Chapman, and A. Kontush Proteomic analysis of defined HDL subpopulations reveals particle-specific protein clusters: relevance to antioxidative function Arterioscler. Thromb. Vasc. Biol. 29 2009 870 876
9. N. Xu, and B. Dahlback A novel human apolipoprotein (apoM) J. Biol. Chem. 274 1999 31286 31290
10. X. Wu, N. Niu, K. Brismar, X. Zhu, X. Wang, S. Efendic, T. Du, Y. Liu, and H.F. Gu Apolipoprotein M promoter polymorphisms alter promoter activity and confer the susceptibility to the development of type 1 diabetes Clin. Biochem. 42 2009 17 21
11. N. Niu, X. Zhu, Y. Liu, T. Du, X. Wang, D. Chen, B. Sun, and H.F. Gu Single nucleotide polymorphisms in the proximal promoter region of apolipoprotein M gene (apoM) confer the susceptibility to development of type 2 diabetes in Han Chinese Diabetes Metab. Res. Rev. 23 2007 21 25 (Pubitemid 46152482)
12. J.W. Zhou, S.K. Tsui, M.C. Ng, H. Geng, S.K. Li, W.Y. So, R.C. Ma, Y. Wang, Q. Tao, Z.Y. Chen, J.C. Chan, and Y.Y. Ho Apolipoprotein M gene (APOM) polymorphism modifies metabolic and disease traits in type 2 diabetes PLoS ONE 6 2011 e17324
13. C. Wolfrum, M.N. Poy, and M. Stoffel Apolipoprotein M is required for prebeta-HDL formation and cholesterol efflux to HDL and protects against atherosclerosis Nat. Med. 11 2005 418 422 (Pubitemid 40562332)
14. C. Christoffersen, M. Jauhiainen, M. Moser, B. Porse, C. Ehnholm, M. Boesl, B. Dahlback, and L.B. Nielsen Effect of apolipoprotein M on high density lipoprotein metabolism and atherosclerosis in low density lipoprotein receptor knock-out mice J. Biol. Chem. 283 2008 1839 1847
15. C. Christoffersen, H. Obinata, S.B. Kumaraswamy, S. Galvani, J. Ahnstrom, M. Sevvana, C. Egerer-Sieber, Y.A. Muller, T. Hla, L.B. Nielsen, and B. Dahlback Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M Proc. Natl. Acad. Sci. U. S. A. 108 2011 9613 9618
16. S. Spiegel, and S. Milstien The outs and the ins of sphingosine-1- phosphate in immunity Nat. Rev. Immunol. 11 2011 403 415
17. M. Maceyka, K.B. Harikumar, S. Milstien, and S. Spiegel Sphingosine-1-phosphate signaling and its role in disease Trends Cell Biol. 22 2012 50 60
18. M. Kurano, K. Tsukamoto, R. Ohkawa, M. Hara, J. Iino, Y. Kageyama, H. Ikeda, and Y. Yatomi Liver involvement in sphingosine 1-phosphate dynamism revealed by adenoviral hepatic overexpression of apolipoprotein M 2013 Atherosclerosis
19. J. Miyazaki, K. Araki, E. Yamato, H. Ikegami, T. Asano, Y. Shibasaki, Y. Oka, and K. Yamamura Establishment of a pancreatic beta cell line that retains glucose-inducible insulin secretion: special reference to expression of glucose transporter isoforms Endocrinology 127 1990 126 132 (Pubitemid 20228111)
20. Y. Yatomi Plasma sphingosine 1-phosphate metabolism and analysis Biochim. Biophys. Acta 1780 2008 606 611 (Pubitemid 351381252)
21. M. Kurano, O.N. Iso, M. Hara, E. Noiri, K. Koike, T. Kadowaki, and K. Tsukamoto Plant sterols increased IL-6 and TNF-alpha secretion from macrophages, but to a lesser extent than cholesterol J. Atheroscler. Thromb. 18 2011 373 383
22. S.G. Laychock, S.M. Sessanna, M.H. Lin, and L.D. Mastrandrea Sphingosine 1-phosphate affects cytokine-induced apoptosis in rat pancreatic islet beta-cells Endocrinology 147 2006 4705 4712 (Pubitemid 44402178)
23. J. Cantrell Stanford, A.J. Morris, M. Sunkara, G.J. Popa, K.L. Larson, and S. Ozcan Sphingosine 1-phosphate (S1P) regulates glucose-stimulated insulin secretion in pancreatic beta cells J. Biol. Chem. 287 2012 13457 13464
24. K. Ueki, T. Okada, J. Hu, C.W. Liew, A. Assmann, G.M. Dahlgren, J.L. Peters, J.G. Shackman, M. Zhang, I. Artner, L.S. Satin, R. Stein, M. Holzenberger, R.T. Kennedy, C.R. Kahn, and R.N. Kulkarni Total insulin and IGF-I resistance in pancreatic beta cells causes overt diabetes Nat. Genet. 38 2006 583 588
25. I.B. Leibiger, B. Leibiger, and P.O. Berggren Insulin signaling in the pancreatic beta-cell Annu. Rev. Nutr. 28 2008 233 251
26. Y. Takuwa, Y. Okamoto, K. Yoshioka, and N. Takuwa Sphingosine-1-phosphate signaling in physiology and diseases Biofactors 38 2012 329 337
27. K. Fujimoto, and K.S. Polonsky Pdx1 and other factors that regulate pancreatic beta-cell survival Diabetes Obes. Metab. 11 Suppl. 4 2009 30 37
28. M. Cnop, F. Foufelle, and L.A. Velloso Endoplasmic reticulum stress, obesity and diabetes Trends Mol. Med. 18 2012 59 68
29. S.G. Fonseca, J. Gromada, and F. Urano Endoplasmic reticulum stress and pancreatic beta-cell death Trends Endocrinol. Metab. 22 2011 266 274
30. H.B. Brewer Jr. Clinical review: the evolving role of HDL in the treatment of high-risk patients with cardiovascular disease J. Clin. Endocrinol. Metab. 96 2011 1246 1257
31. E.A. Podrez Anti-oxidant properties of high-density lipoprotein and atherosclerosis Clin. Exp. Pharmacol. Physiol. 37 2010 719 725
32. Y. Yatomi Sphingosine 1-phosphate in vascular biology: possible therapeutic strategies to control vascular diseases Curr. Pharm. Des. 12 2006 575 587
33. H. Shimizu, F. Okajima, T. Kimura, K. Ohtani, T. Tsuchiya, H. Takahashi, A. Kuwabara, H. Tomura, K. Sato, and M. Mori Sphingosine 1-phosphate stimulates insulin secretion in HIT-T 15 cells and mouse islets Endocr. J. 47 2000 261 269 (Pubitemid 30459111)
34. C. Wolfrum, J.J. Howell, E. Ndungo, and M. Stoffel Foxa2 activity increases plasma high density lipoprotein levels by regulating apolipoprotein M J. Biol. Chem. 283 2008 16940 16949
35. N. Xu, B. Ahren, J. Jiang, and P. Nilsson-Ehle Down-regulation of apolipoprotein M expression is mediated by phosphatidylinositol 3-kinase in HepG2 cells Biochim. Biophys. Acta 1761 2006 256 260
36. T. Kimura, H. Tomura, C. Mogi, A. Kuwabara, A. Damirin, T. Ishizuka, A. Sekiguchi, M. Ishiwara, D.S. Im, K. Sato, M. Murakami, and F. Okajima Role of scavenger receptor class B type I and sphingosine 1-phosphate receptors in high density lipoprotein-induced inhibition of adhesion molecule expression in endothelial cells J. Biol. Chem. 281 2006 37457 37467 (Pubitemid 46042049)
37. B.A. Wilkerson, G.D. Grass, S.B. Wing, W.S. Argraves, and K.M. Argraves Sphingosine 1-phosphate (S1P) carrier-dependent regulation of endothelial barrier: high density lipoprotein (HDL)-S1P prolongs endothelial barrier enhancement as compared with albumin-S1P via effects on levels, trafficking, and signaling of S1P1 J. Biol. Chem. 287 2012 44645 44653
38. E. Rapizzi, M.L. Taddei, T. Fiaschi, C. Donati, P. Bruni, and P. Chiarugi Sphingosine 1-phosphate increases glucose uptake through trans-activation of insulin receptor Cell. Mol. Life Sci. 66 2009 3207 3218